Evaluation of Objective Signs and Subjective Symptoms of Dry Eye Disease in Patients with Inflammatory Bowel Disease

scientific article published on 08 January 2019

Evaluation of Objective Signs and Subjective Symptoms of Dry Eye Disease in Patients with Inflammatory Bowel Disease is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1155/2019/8310583
P932PMC publication ID6341274
P698PubMed publication ID30729131

P50authorRudolf GesztelyiQ42708671
Judit RemenyikQ61472399
Zsolt BartaQ79267706
Adam Kemeny-BekeQ90473327
P2093author name stringPeter Szodoray
Judit Zsuga
Aniko Rentka
Eva Zold
Attila Biro
Levente Czompa
P2860cites workTHE EXTRA-INTESTINAL COMPLICATIONS OF CROHNʼS DISEASE AND ULCERATIVE COLITIS: A STUDY OF 700 PATIENTSQ22242792
LASIK in patients with rheumatic diseases: a pilot study.Q33223496
LASIK outcomes in patients with underlying systemic contraindications: a preliminary studyQ33241546
Ophthalmologic manifestations in patients with inflammatory bowel diseaseQ33819519
A review of quality of life measures in dry eye questionnairesQ34364536
Uveitis and erythema nodosum in inflammatory bowel disease: clinical features and the role of HLA genesQ34800055
The relationship between clinical signs and dry eye symptoms.Q35208749
Outcomes and complications of excimer laser surgery in patients with collagen vascular and other immune-mediated inflammatory diseasesQ36231876
Challenges and pitfalls in clinical trials of treatments for dry eye.Q36639883
Prevalence and Characteristics of Extra-intestinal Manifestations in a Large Cohort of Greek Patients with Inflammatory Bowel DiseaseQ37098461
Prevalence and characteristics of ophthalmological extra-intestinal manifestations in Chinese patients with inflammatory bowel diseaseQ37359860
Minimal clinically important difference for the ocular surface disease indexQ37672025
Managing IBD outside the gut: ocular manifestationsQ38136957
Etiopathogenesis of inflammatory bowel disease: today and tomorrow.Q38840349
Rheumatologic and extraintestinal manifestations of inflammatory bowel diseasesQ38866963
Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of GastroenterologyQ40390478
Ocular manifestations in a community-based cohort of patients with inflammatory bowel diseaseQ43226675
Ocular symptoms are not predictive of ophthalmologic inflammation in inflammatory bowel diseaseQ43998152
Spectrum and frequency of ophthalmologic manifestations in patients with inflammatory bowel disease: a prospective single-center studyQ46483966
Mucins and ocular signs in symptomatic and asymptomatic contact lens wearQ47314621
Clinical tests for successful contact lens wear: relationship and predictive potentialQ47314627
Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies.Q47758448
Exercise and Inflammatory Bowel Disease: Insights into Etiopathogenesis and Modification of Clinical Course.Q49656358
Ocular, Auricular, and Oral Manifestations of Inflammatory Bowel Disease.Q50075113
Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen City and County, 2003-2005: a population-based study from the Danish Crohn colitis database.Q50543867
Controlled release of an HDAC inhibitor for reduction of inflammation in dry eye disease.Q51741521
Ocular complications of inflammatory bowel diseaseQ59121199
Primary, secondary and coincidental ocular complications of Crohn's diseaseQ70790819
The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based studyQ73792791
Reliability and validity of the Ocular Surface Disease IndexQ73801624
Prevalence of and risk factors for dry eye syndromeQ74298539
Etanercept in the treatment of patients with primary Sjögren's syndrome: a pilot studyQ75221575
The prevalence of ocular involvement in patients with inflammatory bowel diseaseQ79687158
Etanercept in Sjögren's syndrome: a twelve-week randomized, double-blind, placebo-controlled pilot clinical trialQ80330602
Ocular manifestations of inflammatory bowel diseaseQ88247623
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P407language of work or nameEnglishQ1860
P921main subjectinflammatory bowel diseasesQ917447
eye diseaseQ3041498
P304page(s)8310583
P577publication date2019-01-08
P1433published inBioMed Research InternationalQ17509958
P1476titleEvaluation of Objective Signs and Subjective Symptoms of Dry Eye Disease in Patients with Inflammatory Bowel Disease
P478volume2019

Search more.